Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma.
Exp Hematol. 2023 May;121:38-47.e2. doi: 10.1016/j.exphem.2023.01.006. Epub 2023 Feb 14.
Exp Hematol. 2023.
PMID: 36796620
Durvalumab Combined with Immunomodulatory Drugs (IMiD) Overcomes Suppression of Antitumor Responses due to IMiD-induced PD-L1 Upregulation on Myeloma Cells.
Ishibashi M, Yamamoto J, Ito T, Handa H, Sunakawa-Kii M, Inokuchi K, Morita R, Tamura H.
Ishibashi M, et al. Among authors: sunakawa kii m.
Mol Cancer Ther. 2021 Jul;20(7):1283-1294. doi: 10.1158/1535-7163.MCT-20-0246. Epub 2021 Apr 20.
Mol Cancer Ther. 2021.
PMID: 33879556
Item in Clipboard
The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma.
Ishibashi M, Sunakawa-Kii M, Kaito Y, Kinoshita R, Asayama T, Kuribayashi Y, Inokuchi K, Morita R, Tamura H.
Ishibashi M, et al. Among authors: sunakawa kii m.
Exp Hematol. 2020 Oct;90:72-79. doi: 10.1016/j.exphem.2020.08.006. Epub 2020 Aug 17.
Exp Hematol. 2020.
PMID: 32818503
Free article.
Item in Clipboard
PD-L1-PD-1 Pathway in the Pathophysiology of Multiple Myeloma.
Tamura H, Ishibashi M, Sunakawa-Kii M, Inokuchi K.
Tamura H, et al. Among authors: sunakawa kii m.
Cancers (Basel). 2020 Apr 10;12(4):924. doi: 10.3390/cancers12040924.
Cancers (Basel). 2020.
PMID: 32290052
Free PMC article.
Review.
Item in Clipboard
Cite
Cite